Does LYMECYCLINE Cause Interstitial lung disease? 8 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 8 reports of Interstitial lung disease have been filed in association with LYMECYCLINE. This represents 4.6% of all adverse event reports for LYMECYCLINE.
8
Reports of Interstitial lung disease with LYMECYCLINE
4.6%
of all LYMECYCLINE reports
0
Deaths
0
Hospitalizations
How Dangerous Is Interstitial lung disease From LYMECYCLINE?
Of the 8 reports, and 8 (100.0%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LYMECYCLINE. However, 8 reports have been filed with the FAERS database.
What Other Side Effects Does LYMECYCLINE Cause?
Drug ineffective (16)
Product use in unapproved indication (16)
Headache (12)
Thrombocytopenia (11)
Myocarditis (10)
Chest pain (9)
Hypersensitivity (9)
Cholestasis (8)
Contraindicated product administered (8)
Dry skin (8)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which LYMECYCLINE Alternatives Have Lower Interstitial lung disease Risk?
LYMECYCLINE vs LYRICA
LYMECYCLINE vs LYSERGIDE
LYMECYCLINE vs MABTHERA
LYMECYCLINE vs MACITENTAN
LYMECYCLINE vs MACITENTAN\TADALAFIL